Table 3.

Multivariable regression of outcome variables at 6-month follow-up for intent-to-treat analyses

	Group†			Time
	B	SE	F-value	B	SE	F-value
Primary outcomes
Cancer coping total	0.082	0.047	2.111	−0.003	0.007	0.185
General coping techniques	0.069	0.056	0.861	0.017	0.008	4.424*
Diversion	0.183	0.067	7.914**	0.005	0.010	0.172
Planning	0.050	0.067	0.090	−0.006	0.012	0.340
Positive outlook	−0.004	0.051	0.673	−0.037	0.011	11.613***
Interpersonal	0.086	0.063	6.201*	0.000	0.008	0.011
Urinary incontinence	1.614	1.614	1.634	1.296	0.216	36.196***
Urinary irritation	−1.436	1.120	1.225	0.904	0.174	25.716***
Bowel dysfunction	−0.014	0.973	0.356	0.149	0.144	0.819
Sexual dysfunction	−1.147	1.747	0.076	0.464	0.120	5.008*
Secondary outcomes
Self-efficacy for re-entry	−0.083	0.088	0.116	0.012	0.012	0.896
Self-efficacy for symptom control	0.033	0.037	0.407	0.010	0.006	2.577
Practical concerns	0.055	0.068	0.780	−0.139	0.012	131.582***
Medical interactions	0.232	0.204	0.172	−0.053	0.031	2.651
Marital interactions	0.716	0.317	4.585*	0.043	0.048	0.735

Note: Analyses controlled for age, income, and treatment. Outcome variables assess change over time from baseline to 6 month follow-up. Reported significance for F-value. Sample size of participants randomized to PROGRESS = 217 and randomized to enhanced usual care = 214.

^†Reference group: Enhanced usual care

^*p < .05;

^**p < .01;

^***p < .001